Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2013-01-18 Board/Management Inform…
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
KEVIN STOLZ RESIGNATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, specifically reporting the resignation of the CFO, Kevin Stolz. The key section is Item 5.02, which deals with departure of officers and election or appointment of directors or officers. The content is about management changes, not financial results, audit, or other report types. The document length is short (2449 characters), and it is a direct report of a management change event. Therefore, it fits the category of Board/Management Information (MANG).
2013-01-18 English
Regulatory Filings 2013
Regulatory Filings
2013-01-14 English
SILBERSTEIN UNGAR, PLLC RESIGNATION
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, reporting the resignation of the company's auditor, Silberstein Ungar, PLLC. It details the auditor's resignation due to non-payment of fees, clarifies that there were no disagreements or adverse opinions, and mentions the delay in filing the Form 10-K. The document includes a resignation letter from the auditor and a letter confirming review of the Form 8-K. This is a regulatory announcement about a change in the auditor and related events, not a full audit report or annual report. It fits best under Regulatory Filings (RNS) as it is a miscellaneous regulatory announcement that does not fit other categories like Audit Report or Annual Report.
2013-01-10 English
NONE
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company Ecology Coatings, Inc. could not file its Form 10-K for the fiscal year ended September 30, 2012, on time due to lack of sufficient financial resources for the independent audit. The document is a notification about the delay in filing the annual report, not the annual report itself. The document length is 4294 characters, which is relatively short and consistent with a notification form rather than a full report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document notifying the SEC of a late filing, not the actual 10-K report.
2012-12-19 English
NICK DEMIRO RESIGNATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 3, 2012. The key content is the resignation of Nick DeMiro from the Board of Directors, which is explicitly stated under Item 5.02 regarding departure of officers and directors. There is no financial data or report attached, only a resignation letter as an exhibit. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short and focused solely on this management change, confirming the classification.
2012-10-03 English
GRAS PATENT AWARD
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 3, 2012. It reports the award of a patent by the United States Patent and Trademark Office and mentions ongoing commercial development efforts. There are no financial statements or exhibits attached, and the content is an announcement of a specific event (patent award) rather than a financial report or detailed management discussion. The document length is short (2611 characters), and it does not contain financial data or detailed analysis. This fits the profile of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into other specific categories.
2012-10-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.